Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SNTI Senti Biosciences Inc.
- Stocks
- Healthcare
- NASDAQ: SNTI
Price (delayed)
$2.2
Market cap
$57.38M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$10.79
Enterprise value
$52.47M
Highlights
SNTI's EPS is up by 25% year-on-year and by 10% since the previous quarter
The debt has decreased by 12% YoY and by 3.3% from the previous quarter
Senti Biosciences's equity has increased by 48% QoQ but it has decreased by 33% YoY
The quick ratio is up by 20% year-on-year but it has declined by 12% since the previous quarter
SNTI's gross profit has dropped by 100% year-on-year
The revenue has plunged by 100% YoY
Key stats
What are the main financial stats of SNTI
Market
Valuations
Earnings
Shares outstanding
26.08M
Market cap
$57.38M
Enterprise value
$52.47M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$61.14M
Net income
-$54.79M
EBIT
-$54.79M
EBITDA
-$49.48M
Free cash flow
-$43.72M
Per share
Balance sheet
Liquidity
EPS
-$10.79
EPS diluted
-$10.79
Free cash flow per share
-$4.37
Book value per share
$1.46
Revenue per share
$0
TBVPS
$8.27
Total assets
$82.78M
Total liabilities
$44.92M
Debt
$32.45M
Equity
$37.86M
Working capital
$34.49M
Debt to equity
0.86
Current ratio
4.22
Quick ratio
3.49
Net debt/EBITDA
0.1
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-67.4%
Return on equity
-177.2%
Return on invested capital
-73.8%
Return on capital employed
-76%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNTI stock price
How has the Senti Biosciences stock price performed over time
Intraday
-0.45%
1 week
4.27%
1 month
-30.16%
1 year
-32.31%
YTD
-37.32%
QTD
4.27%
Financial performance
How have Senti Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$61.14M
Net income
-$54.79M
Gross margin
N/A
Net margin
N/A
SNTI's gross profit has dropped by 100% year-on-year
The revenue has plunged by 100% YoY
SNTI's operating income is up by 35% year-on-year
SNTI's net income is up by 15% YoY but it is down by 3.8% from the previous quarter
Price vs fundamentals
How does SNTI's price correlate with its fundamentals
Growth
What is Senti Biosciences's growth rate over time
Valuation
What is Senti Biosciences stock price valuation
P/E
N/A
P/B
1.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
SNTI's EPS is up by 25% year-on-year and by 10% since the previous quarter
SNTI's P/B is 51% above its last 4 quarters average of 1.0
Senti Biosciences's equity has increased by 48% QoQ but it has decreased by 33% YoY
The revenue has plunged by 100% YoY
Efficiency
How efficient is Senti Biosciences business performance
The ROE has plunged by 108% YoY and by 19% from the previous quarter
The ROA has contracted by 30% YoY and by 10% from the previous quarter
The ROIC is down by 29% year-on-year and by 16% since the previous quarter
Dividends
What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNTI.
Financial health
How did Senti Biosciences financials performed over time
The company's total assets is 84% higher than its total liabilities
SNTI's current ratio is down by 27% year-on-year and by 6% since the previous quarter
The quick ratio is up by 20% year-on-year but it has declined by 12% since the previous quarter
The debt is 14% less than the equity
Senti Biosciences's equity has increased by 48% QoQ but it has decreased by 33% YoY
SNTI's debt to equity is down by 34% since the previous quarter but it is up by 32% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.